Cargando…

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Zanichelli, Andrea, Arcoleo, Francesco, Barca, Maria Pina, Borrelli, Paolo, Bova, Maria, Cancian, Mauro, Cicardi, Marco, Cillari, Enrico, De Carolis, Caterina, De Pasquale, Tiziana, Del Corso, Isabella, Massardo, Ilaria, Minale, Paola, Montinaro, Vincenzo, Neri, Sergio, Perricone, Roberto, Pucci, Stefano, Quattrocchi, Paolina, Rossi, Oliviero, Triggiani, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406698/ http://dx.doi.org/10.1186/1939-4551-8-S1-A184

Ejemplares similares

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)
por: Parente, Roberta, et al.
Publicado: (2023)

Acquired angioedema
por: Cicardi, Marco, et al.
Publicado: (2010)

Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study
por: Savarese, Livia, et al.
Publicado: (2018)

Psychological processes in the experience of hereditary angioedema in adult patients: an observational study
por: Savarese, Livia, et al.
Publicado: (2021)

The impact of puberty on the onset, frequency, location, and severity of attacks in hereditary angioedema due to C1-inhibitor deficiency: A survey from the Italian Network for Hereditary and Acquired Angioedema (ITACA)
por: Cancian, Mauro, et al.
Publicado: (2023)

Secreted Phospholipases A(2) in Hereditary Angioedema With C1-Inhibitor Deficiency
por: Loffredo, Stefania, et al.
Publicado: (2018)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
por: Caballero, T., et al.
Publicado: (2017)

Treatment of hereditary angioedema with recombinant human C1 Inhibitor in a real-life setting: the experience of the HAE Centre in Milan
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction
por: Wu, Maddalena A., et al.
Publicado: (2017)

Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients
por: Federici, Carlo, et al.
Publicado: (2018)

85 Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks
por: Reshef, Avner, et al.
Publicado: (2012)

Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study
por: Zanichelli, Andrea, et al.
Publicado: (2020)

Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor
por: Triggianese, P., et al.
Publicado: (2022)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice
por: Zanichelli, A., et al.
Publicado: (2017)

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor
por: Loules, Gedeon, et al.
Publicado: (2020)

The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures
por: Valerieva, Anna, et al.
Publicado: (2018)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

Oxidative stress markers in patients with hereditary angioedema
por: Del Giacco, Stefano R., et al.
Publicado: (2017)

Roles of Immune Cells in Hereditary Angioedema
por: Ferrara, Anne Lise, et al.
Publicado: (2021)

High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study
por: Squeglia, Veronica, et al.
Publicado: (2016)

Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene
por: Guryanova, Irina, et al.
Publicado: (2021)

Ongoing Contact Activation in Patients with Hereditary Angioedema
por: Konings, Joke, et al.
Publicado: (2013)

Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe
por: Zanichelli, Andrea, et al.
Publicado: (2013)

The experience of living with a chronic disease in pediatrics from the mothers’ narratives: The Clinical Interview on Parental Sense of Grip on the Disease
por: Savarese, Livia, et al.
Publicado: (2020)

Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema
por: Spanò, Rosanna, et al.
Publicado: (2018)

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
por: Longhurst, Hilary J., et al.
Publicado: (2016)

Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy
por: Bova, Maria, et al.
Publicado: (2019)

Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk
por: Reshef, A, et al.
Publicado: (2015)

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges
por: Mormile, Ilaria, et al.
Publicado: (2023)

Evaluation of retinal microvascular perfusion in hereditary angioedema: a case-control study
por: Triggianese, Paola, et al.
Publicado: (2020)

Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study
por: Zanichelli, Andrea, et al.
Publicado: (2018)

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
por: Agostoni, Angelo, et al.
Publicado: (2004)

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
por: Farkas, H., et al.
Publicado: (2016)

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review
por: Tonacci, Alessandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dhbmf9fp967lj7p6muk1la6vjh